Koshinski Asset Management Inc. Acquires 558 Shares of Colgate-Palmolive (NYSE:CL)

Koshinski Asset Management Inc. grew its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 7.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 8,292 shares of the company’s stock after purchasing an additional 558 shares during the quarter. Koshinski Asset Management Inc.’s holdings in Colgate-Palmolive were worth $754,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in CL. Reston Wealth Management LLC bought a new stake in Colgate-Palmolive in the third quarter worth approximately $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive during the 3rd quarter worth $53,000. Prospera Private Wealth LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter worth $64,000. True Wealth Design LLC boosted its holdings in shares of Colgate-Palmolive by 1,460.9% during the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after buying an additional 672 shares during the period. Finally, Continuum Advisory LLC boosted its holdings in shares of Colgate-Palmolive by 93.4% during the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after buying an additional 368 shares during the period. 80.41% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 0.37% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Trading Down 0.8 %

Shares of Colgate-Palmolive stock opened at $87.53 on Thursday. The stock has a market capitalization of $71.51 billion, a P/E ratio of 25.08, a price-to-earnings-growth ratio of 3.64 and a beta of 0.44. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company has a 50-day simple moving average of $92.07 and a 200 day simple moving average of $97.65. Colgate-Palmolive has a 12-month low of $80.03 and a 12-month high of $109.30.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. JPMorgan Chase & Co. decreased their price objective on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. Piper Sandler decreased their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. UBS Group decreased their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a report on Thursday, January 16th. Stifel Nicolaus decreased their price objective on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a report on Friday, January 17th. Finally, StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $101.11.

View Our Latest Stock Analysis on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.